Steven Cepa
AbbVie (United States)(US)
Publications by Year
Research Areas
Synthesis and biological activity, Pharmacogenetics and Drug Metabolism, Analytical Chemistry and Chromatography, Vitamin C and Antioxidants Research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors(2007)117 cited
- → Direct Analysis and Identification of Helicobacter and Campylobacter Species by MALDI-TOF Mass Spectrometry(1999)82 cited
- → Synthesis of specific polychlorinated dibenzo-p-dioxins(1976)65 cited
- → Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315(2018)55 cited
- → Liquid Chromatography Combined with Tandem Mass Spectrometry for the Confirmation of Sarafloxacin in Catfish Tissue(1996)40 cited
- → Intervention of the smiles rearrangement in syntheses of dibenzo--dioxins. 1,2,3,6,7,8- and 1,2,3,7,8,9-hexachlorodibenzo--dioxin (hcdd)(1975)40 cited
- → The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.(1994)37 cited
- → Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors(2017)31 cited
- → Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition(2017)24 cited
- → Glucuronidation of zileuton (A-64077) by human hepatic microsomes.(1992)16 cited